semaglutide deaths 2024 reduced the risk of clinically important kidney outcomes and death from cardiovascular (CV) causes in patients with type 2 diabetes (T2D) and CKD ca. #ERA24 🇸🇪 #Nephpearls https://www.nejm.org/doi/full/10.1056/NEJMoa2403347 New Science Suggests Semaglutide Improves

But a delayed train, a missed connection, an unexpected extra night somewhere rather wonderful these things happen, and having a small buffer keeps your treatment on track whatever the journey throws at you

"People taking semaglutide for weight loss often notice dramatic reductions in hunger and food noise when they begin this treatment

Genetic factors Certain genetic variants affect GLP-1 receptor sensitivity

Food & Drug Administration (FDA-d)

Several antidiabetic agents exert anti-inflammatory effects, as reflected by reductions in circulating inflammatory markers, improved immune cell profiles, decreased adipose tissue inflammation, and attenuation of postprandial hyperglycemia, all of which may contribute to dampening systemic inflammation [90, 91]

[1] Body weight and composition can influence the volume of distribution for GLP-1 medications, potentially affecting elimination kinetics